Skip Navigation Links Cataract > Cataract News

Cataract News

7/29/2010

Eye Vitamin Recalled Over Reports Of Choking

The manufacturer of a softgel supplement marketed as an eye vitamin issued a voluntary recall of the product due to a potential choking hazard.

Source: medpageToday


7/28/2010

Mean IOP Reduction, Medication Number Lowest In Combined Cataract, Stents

Two stents combined with cataract surgery had better outcomes than cataract surgery alone in open-angle glaucoma and ocular hypertension patients, a study found.

Source: Ocular Surgery News


7/28/2010

Omeros Corporation Enrolls First Patient In Phase 2b Clinical Trial Evaluating OMS302 In Patients Undergoing Cataract Surgery

Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery. OMS302, added to standard irrigation solution used during ophthalmologic surgery, is Omeros' proprietary PharmacoSurgery product in development to maintain mydriasis (pupil dilation) and reduce postoperative pain and inflammation following cataract and other lens replacement surgery.

Source: PRNewswire


7/28/2010

Academy Names Medical Director For Governmental Affairs

The American Academy of Ophthalmology has named Michael X. Repka, MD, to the newly created position of Medical Director for Governmental Affairs. The position was created to provide Washington-based physician leadership on Academy issues and critical health care topics being debated on Capitol Hill and before government regulators.

Source: American Academy of Ophthalmology


7/27/2010

Omeros Enrolls First Patient In Phase 2b Clinical Trial Evaluating OMS302 In Patients Undergoing Cataract Surgery

Omeros Corporation , a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery. OMS302, added to standard irrigation solution used during ophthalmologic surgery, is Omeros' proprietary PharmacoSurgery? product in development to maintain mydriasis (pupil dilation) and reduce postoperative pain and inflammation following cataract and other lens replacement surgery.

Source: Omeros Corporation


7/21/2010

Macular Lesions Portend Poor Visual Outcomes In Uveitic Eyes After Cataract Surgery

Phacoemulsification with IOL implantation proved satisfactory in most patients with uveitis, with relatively few complications, a study showed.

Source: Ocular Surgery News


7/21/2010

Successful Pioneering Eye Surgery On Little Girl

Children are left blind by cataracts and other treatable eye diseases on a regular basis, but thanks to a pioneering implant technique, a four-year-old girl has become the first child in this country to benefit from a new procedure to correct bilateral congenital cataracts which affected her both eyes.

Source: Topix


7/20/2010

Clear Corneal, Scleral Incisions Similarly Suitable For MICS

A 2-mm clear corneal incision and a 2-mm scleral tunnel incision proved equally appropriate for microincision cataract surgery, a study showed.

Source: Ocular Surgery News


7/16/2010

Indian Hospital Combats Blindness

Through a mixture of innovative business practices, new technologies and altruism, Aravind Eye Care Hospital created a new model for eliminating “needless blindness” in India, S. Aravind, an ophthalmologist working as an administrator at the hospital, said during a presentation in Kreindler Auditorium this Wednesday. The hospital, which has several locations in the Indian Tamil Nadu state, offers both free and fee-based care.

Source: The Dartmouth


7/16/2010

Study Advises Caution For IOL Implantation In Children 6 Months And Younger

A study examining primary IOL correction of monocular aphakia in infancy found that at 1 year, 63% of children in an IOL implantation-only group needed one or more additional intraocular operations, as opposed to 12% of children in a contact lens-only group.

Source: Ocular Surgery News

Next Page

Sponsored by

The Malyugin ring is least helpful in which of the following cases:




 
advertisement

Upcoming Events

XXVIII Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)

XXVIII Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)

Sep 04 - Sep 08, 2010

Paris, France

More Information

More Events

Newsletters



Write For Us

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing